Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men

https://doi.org/10.1016/0002-9149(93)90355-GGet rights and content

Abstract

Clinical and laboratory findings were compared in 65 women and 238 men with invasively documented idiopathic dilated cardiomyopathy. Women had more severe symptoms (New York Heart Association class ≥III in 48 vs 39%; p < 0.05), presented more frequently with heart failure signs (63 vs 41%; p < 0.01), and had a higher cardiothoracic ratio (0.56 ± 0.06 vs 0.53 ± 0.06; p < 0.05) and higher frequency of left bundle branch block (41 vs 29%; p < 0.05). Echocardiographic measurements in women showed significantly greater left ventricular (LV) end-diastolic (42 ± 7 vs 39 ± 6 mm/m2; p < 0.0001) and end-systolic (36 ± 7 vs 33 ± 6 mm/m2; p < 0.001) diameters, and mean myocardial thickness (11 ± 2 vs 10 ± 2 mm; p < 0.05). Exercise duration was shorter in women than in men (7 ± 3 vs 10 ± 4 minutes; p < 0.001). After 18 ± 16 months, 9 women and 27 men died, and 7 and 17, respectively, received transplants. Transplant-free survival was not significantly different according to gender. By Cox multivariate analysis, LV ejection fraction was a significant independent predictor of cardiac death or heart transplantation in both sexes (p < 0.05 in men, and p < 0.005 in women), together with left atrial diameter index (p < 0.01) in women, and mean pulmonary artery pressure (p < 0.001) in men. In conclusion, women with idiopathic dilated cardiomyopathy present a more advanced phase of the disease with greater LV dilation, but do not have a different prognosis.

References (30)

  • ALP Caforio et al.

    Novel organ-specific circulating autoantibodies in dilated cardiomyopathy

    J Am Coll Cardiol

    (1990)
  • CJ Limas et al.

    Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens

    Am J Cardiol

    (1990)
  • TL Kelly et al.

    Prediction of outcome in late-stage cardiomyopathy

    Am Heart J

    (1990)
  • DG Williams et al.

    Prevalence of overt dilated cardiomyopathy in two regions of England

    Br Heart J

    (1985)
  • MB Codd et al.

    Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy

    Circulation

    (1989)
  • Cited by (78)

    • Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy

      2014, International Journal of Cardiology
      Citation Excerpt :

      Female gender had also shown to be an independent predictor of cardiovascular death in patients with CHF due to ICM or DCM in a prior study by Bistola V et al. [21]. Besides, in an Italian multicenter study [22] of patients with idiopathic dilated cardiomyopathy, women presented with more advanced disease with regard to symptoms and LV dimensions as well as a trend toward poorer prognosis. However, a limiting factor for evaluating gender-related aspects is the small number of women usually included in CHF studies.

    • The role of gender and organ specific autoimmunity

      2012, Autoimmunity Reviews
      Citation Excerpt :

      Several immune-modulating therapies have been suggested and studied in DCM, i.e., IVIG and glucocorticoids [78,87,88]. Nevertheless, it was reported that the occurrence of autoantibodies in idiopathic DCM is unrelated to gender [89]. It remains unknown as to what extent DCM and congestive heart failure (CHF) can be attributable to autoimmune pathophysiology, since proof of autoimmunity requires specialized tests not usually conducted [84].

    • Comparison of women versus men hospitalized with heart failure (from a 20-year registry in a Middle-Eastern country 1991-2010)

      2012, American Journal of Cardiology
      Citation Excerpt :

      During the 20-year study period, an overall improvement in survival occurred in the patients with HF, regardless of gender. The prevalence and clinical characteristics of women hospitalized for HF has been described by many investigators6–22,25–29 (Table 5). Some of these studies were single- or multicenter center registries,8,9,12,14,16,17,19–21,22,26–28 and others were post hoc analyses of randomized trials.6,7,10,11,13,15,18,25

    View all citing articles on Scopus

    This work was supported in part by the National Research Council (CNR, Rome, Italy)-Targeted Project “Prevention and Control of Disease Factors,” Subproject “Control of Cardiovascular Disease” Grant 104299/41/9103611.

    See Appendix.

    View full text